PuSH - Publication Server of Helmholtz Zentrum München

Berthold, H.K.* ; Michalke, B. ; Krone, W.* ; Guallar, E.* ; Gouni-Berthold, I.*

Influence of serum selenium concentrations on hypertension: The Lipid Analytic Cologne cross-sectional study.

J. Hypertens. 30, 1328-1335 (2012)
Publ. Version/Full Text Volltext DOI PMC
Open Access Gold
Aims: Selenium is an antioxidant micronutrient with potential associations with hypertension. Few studies have investigated the association of serum selenium concentrations with blood pressure and hypertension in countries with low dietary selenium intake such as Germany, with inconsistent findings. Methods: We undertook a cross-sectional analysis of participants in the Lipid Analytic Cologne (LIANCO) cohort. To reduce potential confounding, we restricted the analysis to 792 participants who were never smokers, who did not use antihypertensive medications, and who did not have diabetes or known atherosclerotic disease. Hypertension was defined as blood pressure at least 140 and/or at least 90 mmHg. About half of the cohort was diagnosed as hypertensive. Selenium was measured by inductively coupled plasma-dynamic reaction cell-mass spectrometry (ICP-DRC-MS). Results: Mean +/- standard deviation (SD) serum selenium concentration was 68 +/- 32 mu g/l. The multivariable adjusted differences (95% confidence intervals) in blood pressure levels comparing the highest (>91.9 mu g/l) to the lowest (<= 42.8 mu g/l) quartile of serum selenium were 5.2 (1.4 to 8.9), 2.8 (0.7 to 4.8), and 2.4 (-0.4 to 5.2) mmHg for systolic, diastolic, and pulse pressure, respectively (P for trend for all <0.003). The corresponding multivariable adjusted odds ratio for the presence of hypertension was 1.52 (0.98 to 2.36; P trend = 0.004). Conclusions: The data suggest that even in a population with very low serum selenium concentrations higher serum selenium concentrations are associated with higher blood pressure levels and a higher prevalence of hypertension. These findings call for careful evaluation of the effects of selenium on blood pressure endpoints in randomized clinical trials.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.021
1.553
26
29
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Blood Pressure; Hypertension; Selenium; Trace Elements; CORONARY-HEART-DISEASE; DIABETES-MELLITUS TYPE-2; BLOOD-PRESSURE; US ADULTS; RANDOMIZED-TRIAL; HEALTHY-ADULTS; RISK; ANTIOXIDANT; POPULATION; SUPPLEMENTATION
Language english
Publication Year 2012
HGF-reported in Year 2012
ISSN (print) / ISBN 0263-6352
e-ISSN 1473-5598
Quellenangaben Volume: 30, Issue: 7, Pages: 1328-1335 Article Number: , Supplement: ,
Publisher Lippincott Williams & Wilkins
Reviewing status Peer reviewed
POF-Topic(s) 30202 - Environmental Health
Research field(s) Environmental Sciences
PSP Element(s) G-504800-002
PubMed ID 22573120
Scopus ID 84862770031
Erfassungsdatum 2012-07-12